The knockdown of Snai2 reduced the AML oncogene (NUP98-HOXA9 and MLL-AF9) ability to alter the mouse HSCs, which showed that SNAI2 is important for the transformation of oncogene and AML progression. This evidence concerns the gene MLLT3 and acute myeloid leukemia.